Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

NCT07101640 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT07101640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07101640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
Lead sponsor
Duke University
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 23, 2026
Completion date
June 30, 2028
Enrollment
28 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia (bpd), critical illness, premature births